deltatrials
Completed OBSERVATIONAL NCT03502993

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM) (PERFORM)

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions Fever Infection Inflammation
Interventions Validation of biomarker
Updated 15 times since 2018 Last updated: Oct 12, 2023 Started: Jun 2, 2016 Primary completion: Jan 25, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Fever and Infection, this trial is completed. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 15 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Jun 2019 · 5 months · monthly snapshot~Jun 2019 – ~Nov 2020 · 17 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2023 · 21 months · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – present · 16 months · monthly snapshot

Change History

15 versions recorded

  1. Mar 2025 — Present [monthly]

    Completed

  2. Feb 2025 — Mar 2025 [monthly]

    Completed

  3. Sep 2024 — Feb 2025 [monthly]

    Completed

  4. Jul 2024 — Sep 2024 [monthly]

    Completed

  5. Nov 2023 — Jul 2024 [monthly]

    Completed

    Status: Unknown Status → Completed

▶ Show 10 earlier versions

  1. Sep 2023 — Nov 2023 [monthly]

    Unknown Status

    Status: Active Not Recruiting → Unknown Status

  2. Dec 2021 — Sep 2023 [monthly]

    Active Not Recruiting

  3. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  4. Feb 2021 — Sep 2021 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  7. Jun 2019 — Nov 2020 [monthly]

    Recruiting

  8. Jan 2019 — Jun 2019 [monthly]

    Recruiting

  9. Jun 2018 — Jan 2019 [monthly]

    Recruiting

  10. May 2018 — Jun 2018 [monthly]

    Recruiting

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • BioMérieux
  • Erasmus Medical Center
  • Imperial College London
  • London School of Hygiene and Tropical Medicine
  • Ludwig-Maximilians - University of Munich
  • Medical Research Council Unit, The Gambia
  • Micropathology Ltd, University of Warwick
  • National and Kapodistrian University of Athens
  • Riga Stradins University
  • Servicio Gallego de Salud
  • Stichting Katholieke Universiteit
  • University Hospital, Paris
  • University of Bern
  • University of Graz
  • University of Liverpool
  • University of Ljubljana
  • University of Newcastle Upon-Tyne
  • University of Oxford
  • University of Santiago de Compostela
Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations